CD4 and myeloid sarcoma: Importantly, the study found reduced numbers of CD4+ T cells in the CNS of EAE mice which received EBI2 deficient Th17 cells demonstrating that modifications of EBI2/7α, 25OHC signalling reduces CNS infiltration by the most encephalitogenic cell type in MS.